It’s showtime for stem cells in San Diego

Print Friendly, PDF & Email

San Diego research centers have banded together to bring in stem cell grants, getting more than $261 million. Local leaders calculated there would be commercial benefits as well, reinforcing San Diego’s stature as one of the world’s top biotech centers. Now, commercialization is starting to take place. Local biotechs are testing stem cell therapies in patients, in the United States, in Europe and in China.

Cures for diabetes, heart failure, and even baldness are being developed by San Diego companies; the last two already being tested in patients. While these treatments are still experimental — success is far from certain — they provide a preliminary indication that regenerative medicine is on the road to becoming a new growth area for the region’s large biotechnology industry.

View the original article here: SHOWTIME FOR STEM CELLS

Outbreak Featured
Infographic: Autoimmune diseases — 76 identified so far — tend to target women over men. Here is a master list

Infographic: Autoimmune diseases — 76 identified so far — tend to target women over men. Here is a master list

There are many autoimmune diseases, and taken together they affect as much as 4.5 percent of the world’s population. This ...
Are GMOs and pesticides threatening bees?

Are GMOs and pesticides threatening bees?

First introduced in 1995, neonicotinoids ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.